Claims for Patent: 11,845,867

Summary for Patent: 11,845,867

Title:	Process for the preparation of indigotindisulfonate sodium (indigo carmine)
Abstract:	This invention relates to an improved method for the preparation of highly or substantially pure Indigotindisulfonate sodium (1). It further relates to the novel crystalline form I of Indigotindisulfonate sodium (1) and the process for its preparation.
Inventor(s):	Manik Reddy Pullagurla, Jagadeesh Babu Rangisetty
Assignee:	Provepharm Life Solutions SA
Application Number:	US18/045,584
Patent Claims:	1. Indigotindisulfonate sodium of formula (I) in a crystalline form having a purity greater than 99.0% by HPLC at 245 nm 2. The Indigotindisulfonate sodium of formula (I) of claim 1, wherein the crystalline form is characterized by an X-ray powder diffraction (XRPD) pattern comprising peaks at 11.67, 20.31, and 26.54 degrees 2 theta±0.2 degrees 2 theta. 3. The Indigotindisulfonate sodium of formula (I) of claim 2, wherein the X-ray powder diffraction (XRPD) pattern further comprises peaks at 5.80, 15.37, and 17.62 degrees 2 theta±0.2 degrees 2 theta. 4. The Indigotindisulfonate sodium of formula (I) of claim 3, wherein the X-ray powder diffraction (XRPD) pattern further comprises peaks at 14.4, 20.97, 24.03, 24.72, 27.16, 28.65, and 40.97 degrees 2 theta±0.2 degrees 2 theta. 5. The Indigotindisulfonate sodium of formula (I) of claim 1, wherein the purity is greater than 99.5% by HPLC at 245 nm. 6. The Indigotindisulfonate sodium of formula (I) of claim 1, wherein the purity is 99.9% by HPLC at 245 nm. 7. The Indigotindisulfonate sodium of formula (I) of claim 1, comprising less than 0.15% of impurity (A) by HPLC at 245 nm 8. The Indigotindisulfonate sodium of formula (I) of claim 1, comprising less than 0.15% of impurity (B) by HPLC at 245 nm 9. The Indigotindisulfonate sodium of formula (I) of claim 1, comprising less than 0.15% of impurity (C) by HPLC at 245 nm 10. The Indigotindisulfonate sodium of formula (I) of claim 1, wherein any unknown impurity is less than 0.10% by HPLC at 245 nm. 11. The Indigotindisulfonate sodium of formula (I) of claim 1, comprising less than 2 ppm of lead and arsenic combined. 12. The Indigotindisulfonate sodium of formula (I) of claim 1, comprising less than 0.5 ppm of lead. 13. The Indigotindisulfonate sodium of formula (I) of claim 1, comprising less than 1.5 ppm of arsenic. 14. The Indigotindisulfonate sodium of formula (I) of claim 1, comprising from 4 to 7% of moisture content. 15. The Indigotindisulfonate sodium of formula (I) of claim 1, obtained by a process comprising: suspending crude Indigotindisulfonate sodium in a protic or an aprotic solvent to obtain a suspension; heating the suspension to 60-65°0 C.; cooling the suspension to 20-25° C.; and filtering the suspension and washing with methanol at 20-25° C. to isolate pure crystalline Indigotindisulfonate sodium. 16. The Indigotindisulfonate sodium of formula (I) of claim 15, wherein the protic or aprotic solvent is selected from the group consisting of water, methanol, ethanol, isopropyl alcohol, n-butanol, acetonitrile, tetrahydrofuran, acetone, ethyl acetate, dichloromethane, and mixtures thereof.